Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer.

R E Frank1

  • 1resafrank@aol.com

Journal of Insurance Medicine (New York, N.Y.)
|August 21, 2001
PubMed
Summary
This summary is machine-generated.

Prostate cancer prognosis is influenced by several factors, notably the Gleason score. Post-treatment PSA levels also provide significant prognostic information for American males.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membranoproliferative glomerulonephritis.

Journal of insurance medicine (New York, N.Y.)·2005
Same author

Approach scar revisions after self-inflicted wounds with caution.

Plastic and reconstructive surgery·2000
Same author

Psoriatic arthritis.

Journal of insurance medicine (New York, N.Y.)·1999
Same author

Myocardial bridging.

Journal of insurance medicine (New York, N.Y.)·1999
Same author

Supraventricular tachycardia vs. Marfan's syndrome.

Journal of insurance medicine (New York, N.Y.)·1996
Same author

Membranous nephropathy: case study.

Journal of insurance medicine (New York, N.Y.)·1995
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026
See all related articles

Area of Science:

  • Oncology
  • Urology

Background:

  • Prostate cancer is a leading internal malignancy in American men.
  • Prognostic variables significantly impact patient outcomes.
  • The Gleason scoring system is a critical factor in prostate cancer prognosis.

Observation:

  • Treatment decisions for prostate cancer subsets remain debated.
  • Post-treatment prostate-specific antigen (PSA) levels are recognized for their prognostic value.

Findings:

  • The Gleason score is a key determinant of prostate cancer prognosis.
  • Elevated post-treatment PSA levels indicate prognostic significance.

Implications:

  • Accurate prognostic assessment is vital for tailoring prostate cancer treatment strategies.
  • Further research into optimal treatment protocols based on prognostic factors is warranted.